Henry Schein, Inc. (HSIC) vs 10x Genomics, Inc. (TXG)

A side-by-side comparison of Henry Schein, Inc. and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HSIC vs TXG

growth of $100 · dividends reinvested · last 7y
HSIC +36.8% (+4.6%/yr)TXG +85.3% (+9.2%/yr)TXG compounded faster over this window
0100200300400Start $100202120232025$137$185
HSIC TXG

HSIC vs TXG: by the numbers

  • •TXG is the larger company ($10.24B vs $9.66B market cap).
  • •HSIC is profitable (2.96% net margin) while TXG runs a net loss (-12.18%).
  • •TXG grew revenue faster over the past five years (8.74% vs 2.71% CAGR).

Metrics side by side

Valuation

MetricHSICTXG
P/E ratio24.73N/A
Forward P/E15.75N/A
PEG ratio7.83N/A
P/S ratio0.7116.60
P/B ratio3.0612.40
EV / EBITDA12.25N/A
FCF yield5.58%1.19%

Profitability

MetricHSICTXG
Gross margin30.31%70.03%
Operating margin5.69%-14.33%
Net margin2.96%-12.18%
ROE12.77%-9.10%
ROIC6.53%-9.57%

Growth (annualized)

MetricHSICTXG
Revenue CAGR (5Y)2.71%8.74%
EPS CAGR (5Y)3.14%N/A
FCF CAGR (5Y)0.82%N/A
Total return CAGR (5Y)1.39%-7.24%

Frequently asked

Which has grown faster, HSIC or TXG?
Over the past five years, TXG grew revenue faster — HSIC at a 2.71% CAGR versus TXG at 8.74%.
Is HSIC or TXG more profitable?
HSIC runs the higher net margin — HSIC at 2.96% versus TXG at -12.18%.
How have HSIC and TXG total returns compared?
Over the past 5 years, HSIC delivered 1.39% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.